Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 345.00p 330.00p 360.00p 345.00p 345.00p 345.00p 25,429 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 74.6 15.2 17.6 19.6 233

Eco Animal Health Share Discussion Threads

Showing 1051 to 1075 of 1075 messages
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
DateSubjectAuthorDiscuss
13/10/2019
20:11
An article from earlier in the week on AFS in China which suggests that the disease is not going away any time soon https://www.ft.com/content/ebb0b042-e428-11e9-b112-9624ec9edc59 Not yet tempted to add but keeping share price under review.
cerrito
07/10/2019
09:42
Will put links in header cheers
waldron
07/10/2019
09:41
Https://www.stockopedia.com/share-prices/eco-animal-health-LON:EAH/dividends/ DIVIDEND PAY DATE 16th OCTOBER 2019
waldron
07/10/2019
09:34
Http://uk.stoxline.com/q_uk.php?s=EAH Moving Averages analysis Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term. Bollinger Bands Analysis EAH.L has closed above bottom band by 20.4%. Bollinger Bands are 81.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to EAH.L's normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.
adrian j boris
07/10/2019
09:24
Https://www.britishbulls.com/m/SignalPage.aspx?lang=en&Ticker=EAH.L ast Signal: STAY SHORT Last Close: 353.00 Change: 0.0000 Percent change 0.00% Signal Update Our system’s recommendation today is to STAY SHORT. The previous SHORT signal was issued on 08/08/2019, 57 days ago, when the stock price was 395.59. Since then EAH.L has fallen by -10.77%. Market Outlook Bear market rallies may be vicious reversals, giving hard times to those holding short positions; so, it is better to be on alert.
adrian j boris
07/10/2019
09:18
NO IDEA lol One presumes they have been thorough in their analysis and not used an algo robot certainly only covered by two analyst it seems with one without opinion Https://www.marketscreener.com/ECO-ANIMAL-HEALTH-GROUP-P-4003649/consensus/
adrian j boris
07/10/2019
08:51
Ajb, do Peel Hunt have a rationale and a timeframe or are they using the hopeful MifidII finger in the air again?
steve3sandal
07/10/2019
08:38
Peel Hunt Buy 600.00 - Reiterates
adrian j boris
23/9/2019
20:10
Yes, interesting. I am a bit puzzled on the various board movements, including the sudden retirement of Peter Lawrence and then the new Chairman.
topvest
23/9/2019
03:50
Thanks for posting Cerrito, appreciated
tudes100
22/9/2019
23:10
A good meeting ; only four shareholders there but plenty of questions. I came away with little desire to add and zero desire to sell. I have had shares since July last year and this was the first AGM I have been to. All resolutions passed easily with a very high voter turnout at least for an AIM company-51m out of 67m shares voted. The meeting was chaired by one of the non execs as the interim chairman Andrew Jones was apparently ill. This meant that not unnaturally the CEO dominated the q&a but I would be reluctant to deduce from that that he dominated the board, although long term holders will be a better judge of that. We were told that the reason Wood left was so abruptly and quickly was that he came in to do the specific job of sorting out corporate governance and he had accomplished this. Nobody was indelicate enough to ask why he had not hung around to appoint the new Chairman, especially as in the AR he talked about being there for 6 months.. No real comment on the change of FD-the new one seemed a good appointment but as this is my first AGM I have no view of the previous one. All very strange and I have not worked out how damaging to the company-guess we need to reserve judgement till we see the credentials and strength of the new chairman. They are looking for a new chairman with an understanding of the biological markets. They are continuing with their strategy of investing in R&D as outlined in the AR and of course we have had the two Pirbright RNS. Incidentally this coming year will be the first audit of the new auditors. They will be using their offices in Uk and China and the US operation will continue to be audited by the same company who have audited them for the last few years. China A good discussion on this. Question asked about huge expansion of receivables in RMB. Told that their response to the competitive pressures in China following ASF was not to cut margins but extend credit terms. Told that as at end of September RMB receivables will have declined and current indications are there will be no change in the aging of receivables as per Note 19. With hindsight I should have got a better understanding of the JV arrangement in China and how it works. Given the very high pork prices in China the whole pork industry will become a big political issue as the Chinese New Year approaches and the stocks of frozen pork is run down. Indeed we have the situation of lack of pork in China and excess in US/Canada…if I understood it there are issues with Canadian pork exports to China because there were exports of US pork rebranded as Canadian. Factory relocation was as the old one was located in a residential area. Site has been inspected not only by Chinese authorities but also by FDA who went on site and an Independent third party inspector and as a result of this there has been sign off from the relevant authorities in many countries. Pre ASF 98% of sales were to pork sector and 2% to poultry. Repeated what they said in the AR that as a result of this the industry is consolidating and becoming more professional ie moving away from feeding pigs with swill. They have a 60/65 sales team across China- well smaller than some of their competitors. They still cannot get to the farms and so doing seminars in the local towns and seminars on line. Rest of Asia Did not get clear insight into spread of ASF. Basically sell more to poultry than pork markets except Thailand where pork sales are bigger and the industry is concentrated. Americas They are going on the basis that ASF will not come to US/Canada because of very high hygiene standards. In the short term and until the tariff issue is resolved, sales will be subdued but should go well in Latam where they are putting in additional resources. R&D They will focus on pigs and poultry and for now pass on aquaculture.Focusing on vaccines which are quicker and less costly to develop.-see Sept 11 RNS. Newsflow We await the interims in December and news of new Chairman as well as any major ASF developments.
cerrito
04/9/2019
19:59
Yes, agreed. One of these collaborations could well come off big time at some point. A nice to have.
topvest
04/9/2019
11:39
Nice to see some diversification.
audigger
22/8/2019
12:31
Yes, all a bit odd. We will find out later no doubt, rather than now as we should have been. Like auditors I think it would be helpful if directors were required by law to explain the reason for their resignation.
topvest
22/8/2019
09:22
Cerrito you probably understand EAH and ANP better than many of us. However, I always thought it odd when Peter Lawrence, Anpario's chairman, resigned as long-time chairman of Eco Animal Healthcare, which he founded in 1972, and was replaced as chairman by Richard Wood, Anpario's senior independent director. Given that both companies have a number of institutional investors on their share register, perhaps the change was triggered by corporate governance concerns about the independence of two companies with unusually close boardroom ties. As a non-expert, I would be interested to know whether there is much competitive overlap between the two companies.
bottomfisher
22/8/2019
07:40
I would appreciate any insight from old hands here as to Richard Wood stepping down with immediate effect. There was no hint in the March 2019 RNS announcing his arrival on the board that his role was restricted to the board restructuring. I am never sure in cases like this whether there is a clash on strategy or a personality clash or perhaps while a very successful businessman he was not a good chairman. My only contact with him was at the Anpario AGM where he impressed me by taking the effort to meet and great all shareholders.
cerrito
09/8/2019
13:18
Cerrito - think you have just been a tad unlucky. ASF is behind the weakness. Just to firm up on the Chinese numbers, they are not quite as significant as you think. China makes c£4m net profit per annum, but the impact on the group is only £2m as there is a 52% minority interest. See pages 80 and 93. Provided ASF doesn’t move around the world, other territories should be fairly buoyant and are wholly owned so pound for pound, twice as valuable.
topvest
09/8/2019
12:42
Yes, taken a look myself. ASF could well lead to further downgrades this year, and presumably things will take a while to recover. https://www.cnbc.com/2019/08/09/china-inflation-july-2019-producer-prices-ppi-and-consumer-price-index-cpi.html In the end, China will no doubt bounce back. £5 is probably fair value here. If you look at the value in use numbers in note 11 there is c£168m to £287m of headroom by my reckoning.
topvest
07/8/2019
08:28
Insightful post. share price doesn't like it though! The other difficult aspect to gauge is how much incremental sales they will secure from all the recent (last 2 years) approvals, especially egg laying hens which is big business. There must be still good opportunity for further growth through continued new approvals of aivlosin. Diversification though is key for longer-term sustainability.
audigger
06/8/2019
16:46
I have gone through the annual report. Given ASF I feel I am flying blind here. I have no idea as to how much revenue and profit(however defined) comes from pigs as compared to poultry,cattle etcet. I can get nothing from the media as to what is happening in China with ASF; there are stories of it being in neighbouring countries to China and very recent outbreaks in Bulgaria and Romania and the concern it may go into Germany etcet. Luckily it does not appear to have made its way to the Americas. I hope I can make the AGM to get some clarity here. To get an idea of the importance of China remember that in 17/18 Far East(and I assume that China is the biggest contributor here) produced £14m out of the £22m adjusted ebitda. Also note per page 14 of the AR, that Chinese subsidary’s reported operating profit fell between the years from £6.4m to £5.2m. Difficult to know how this figure compares with total Group Profit from operations which went up from £14.1m to £14.7m. Page 85 tells us that of the £29.5m trade receivables at FYE, £9m were in RMB-though that high percentage would have been distorted because of extended credit terms in China. Finally page 97 shows that last year profits were more sensitive to a change in RMB FX rate than US$ rate(which makes sense given that they are both importing and exporting in US$) with a 10% change in the RMB/£ rate impacting profit by £788k. For me the upshot of these random figures is that we need to have a good handle of what is happening in China given its importance to EAH. I am going on the basis that the share price will wait to see how effective the development expenditure which will go from £3.7m in 17/18, to £5.3m in 18/19 and to £9m in 19/20 given that it will not feed through to sales till 22/23. For me good that wanting to diversify away from aivlosin. Interesting that they have £10m+of UK tax losses which no doubt will increase given r&d expenditure. Be interesting to know how they are going to deal with this situation, Also interesting to see the change in shareholder composition between June 18 and June 19. EAH has important institutional backing-institutions with 3%+ are approx. 60% of shareholding as of June 19 which added to the 10% held by the Lawrence family suggests why there is a wide trading margin. Merian/Old Mutual have gone from 8% to 4% and Schroder from 11% to 7% and we seem to have said hello to Blackrock with 4%. I find their treatment of administrative expenses frustrating-they were £7m in H1 and £12m in H1 and H2 18/19 FY and not clear why they rose between the halves; for 17/18 the July 2 2018 prelims announcement had them as £18.5m and then in the December 10 2018 Interims RNS said that 17/18m admin expenses were £13.4m which does not improve one’s mood. The truth is that I have messed up here as I have an average in price of £4.85 and difficult to see it getting back there any time soon. I hope I can make the AGM.
cerrito
01/8/2019
16:50
Encouraging to see that someone is confident enough to have bought 200,000 shares this morning.
aimingupward2
01/8/2019
14:50
September Annual general meeting
waldron
01/8/2019
11:35
EAH Peel Hunt Buy 600.00 - Reiterates
maywillow
17/7/2019
11:45
Well its taking a hit today!
audigger
03/7/2019
07:43
EAH Peel Hunt Buy 600.0 Reiterates CVSG Peel Hunt Buy 775.00 - Reiterates
grupo
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
Your Recent History
LSE
EAH
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191018 14:26:27